In Vivo Switch to IL-10-secreting T Regulatory Cells in High Dose Allergen Exposure

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2008 Nov 13

PMID 19001136

Citations 170

Authors

Flurina Meiler

Judith Zumkehr

Sven Klunker

Beate Ruckert

Cezmi A Akdis

Mubeccel Akdis

Affiliations

Soon will be listed here.

Abstract

High dose bee venom exposure in beekeepers by natural bee stings represents a model to understand mechanisms of T cell tolerance to allergens in healthy individuals. Continuous exposure of nonallergic beekeepers to high doses of bee venom antigens induces diminished T cell-related cutaneous late-phase swelling to bee stings in parallel with suppressed allergen-specific T cell proliferation and T helper type 1 (Th1) and Th2 cytokine secretion. After multiple bee stings, venom antigen-specific Th1 and Th2 cells show a switch toward interleukin (IL) 10-secreting type 1 T regulatory (Tr1) cells. T cell regulation continues as long as antigen exposure persists and returns to initial levels within 2 to 3 mo after bee stings. Histamine receptor 2 up-regulated on specific Th2 cells displays a dual effect by directly suppressing allergen-stimulated T cells and increasing IL-10 production. In addition, cytotoxic T lymphocyte-associated antigen 4 and programmed death 1 play roles in allergen-specific T cell suppression. In contrast to its role in mucosal allergen tolerance, transforming growth factor beta does not seem to be an essential player in skin-related allergen tolerance. Thus, rapid switch and expansion of IL-10-producing Tr1 cells and the use of multiple suppressive factors represent essential mechanisms in immune tolerance to a high dose of allergens in nonallergic individuals.

Citing Articles

Pathogenic and Nonpathogenic Antibody Responses in Allergic Diseases.

Ehlers M, Jonsson F Eur J Immunol. 2025; 55(3):e202249978.

PMID: 40071673 PMC: 11898564. DOI: 10.1002/eji.202249978.

Pattern of sensitization to yellow jacket venom and expression of recombinant antigen 5 (Ves v 5) from yellow jacket venom.

Mahmoudzadeh S, Rezapour H, Chamani S, Safarpour H, Fereidouni M BMC Immunol. 2025; 26(1):14.

PMID: 40050709 PMC: 11883983. DOI: 10.1186/s12865-025-00689-5.

Type 2 immunity in allergic diseases.

Ogulur I, Mitamura Y, Yazici D, Pat Y, Ardicli S, Li M Cell Mol Immunol. 2025; 22(3):211-242.

PMID: 39962262 PMC: 11868591. DOI: 10.1038/s41423-025-01261-2.

Disturbances of Ruminal Microbiota and Liver Inflammation, Mediated by LPS and Histamine, in Dairy Cows Fed a High-Concentrate Diet.

Ma N, Guo J, Li Z, Xu L, Zhang K, Xu T Animals (Basel). 2024; 14(10).

PMID: 38791713 PMC: 11117260. DOI: 10.3390/ani14101495.

Are There General Features of How Immune Responses Are Regulated That Can Provide Clues to How Remitting/Relapsing Multiple Sclerosis May Be Treated?.

Bretscher P Int J Mol Sci. 2024; 25(5).

PMID: 38473972 PMC: 10932258. DOI: 10.3390/ijms25052726.

References

Hill J, Benoist C, Mathis D . Treg cells: guardians for life. Nat Immunol. 2007; 8(2):124-5. DOI: 10.1038/ni0207-124. View

Shevach E, Dipaolo R, Andersson J, Zhao D, Stephens G, Thornton A . The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev. 2006; 212:60-73. DOI: 10.1111/j.0105-2896.2006.00415.x. View

Mazzoni A, Young H, Spitzer J, Visintin A, Segal D . Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest. 2001; 108(12):1865-73. PMC: 209473. DOI: 10.1172/JCI13930. View

Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K . IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol. 2003; 33(5):1205-14. DOI: 10.1002/eji.200322919. View

Texier C, Pouvelle S, Busson M, Herve M, Charron D, Menez A . HLA-DR restricted peptide candidates for bee venom immunotherapy. J Immunol. 2000; 164(6):3177-84. DOI: 10.4049/jimmunol.164.6.3177. View

Bacchetta R, Sartirana C, Levings M, Bordignon C, Narula S, Roncarolo M . Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol. 2002; 32(8):2237-45. DOI: 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2. View

van der Pouw Kraan T, Snijders A, Boeije L, de Groot E, Alewijnse A, Leurs R . Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest. 1998; 102(10):1866-73. PMC: 509137. DOI: 10.1172/JCI3692. View

Tarzi M, Klunker S, Texier C, Verhoef A, Stapel S, Akdis C . Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy. 2006; 36(4):465-74. DOI: 10.1111/j.1365-2222.2006.02469.x. View

Roncarolo M, Battaglia M . Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007; 7(8):585-98. DOI: 10.1038/nri2138. View

10.

Vukmanovic-Stejic M, Zhang Y, Cook J, Fletcher J, McQuaid A, Masters J . Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest. 2006; 116(9):2423-33. PMC: 1555646. DOI: 10.1172/JCI28941. View

11.

Cong Y, Weaver C, Lazenby A, Elson C . Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol. 2002; 169(11):6112-9. DOI: 10.4049/jimmunol.169.11.6112. View

12.

Larche M, Akdis C, Valenta R . Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol. 2006; 6(10):761-71. DOI: 10.1038/nri1934. View

13.

Carter L, Fouser L, Jussif J, Fitz L, Deng B, Wood C . PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol. 2002; 32(3):634-43. DOI: 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9. View

14.

Golden D, Marsh D, Freidhoff L, Kwiterovich K, Addison B, Lichtenstein L . Natural history of Hymenoptera venom sensitivity in adults. J Allergy Clin Immunol. 1998; 100(6 Pt 1):760-6. DOI: 10.1016/s0091-6749(97)70270-7. View

15.

Kunzmann S, Wohlfahrt J, Itoh S, Asao H, Komada M, Akdis C . SARA and Hgs attenuate susceptibility to TGF-beta1-mediated T cell suppression. FASEB J. 2003; 17(2):194-202. DOI: 10.1096/fj.02-0550com. View

16.

Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R . Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004; 199(11):1567-75. PMC: 2211782. DOI: 10.1084/jem.20032058. View

17.

Van Parijs L, Abbas A . Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 1998; 280(5361):243-8. DOI: 10.1126/science.280.5361.243. View

18.

Akdis C, Blesken T, Akdis M, Wuthrich B, Blaser K . Role of interleukin 10 in specific immunotherapy. J Clin Invest. 1998; 102(1):98-106. PMC: 509070. DOI: 10.1172/JCI2250. View

19.

Ying S, Meng Q, Barata L, Robinson D, Durham S, Kay A . Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Immunol. 1997; 158(10):5050-7. View

20.

Brosterhus H, Brings S, Leyendeckers H, Manz R, Miltenyi S, Radbruch A . Enrichment and detection of live antigen-specific CD4(+) and CD8(+) T cells based on cytokine secretion. Eur J Immunol. 1999; 29(12):4053-9. DOI: 10.1002/(SICI)1521-4141(199912)29:12<4053::AID-IMMU4053>3.0.CO;2-C. View